Diebold Nixdorf
DBD · NYSE
About DBD
- Employees
- 20,000
- Headquarters
- North Canton, Ohio
- Listed
- Mar 17, 1980
- Sector
- Information Technology
- Industry
- Technology Hardware, Storage & Peripherals
- Website
- dieboldnixdorf.com
DBD key statistics
- Market cap
- 2.29B
- Price-earnings ratio
- 22.30
- Dividend yield
- —
- Average volume
- 225.51K
- Volume
- 167.13K
- Open price
- $67.89
- High today
- $68.95
- Low today
- $67.55
- 52 Week high
- $92.09
- 52 Week low
- $54.48
Diebold Nixdorf (DBD) at a glance
As of Oct 20, 2026, Diebold Nixdorf (DBD) shares are priced at $67.84, giving the company a market cap of 2.29B and a price-to-earnings ratio of 22.30.
Today the stock has traded between $67.55 and $68.95. The current price is 0.4% above the day's low and 1.6% below its high.
Volume so far is 167.13K shares, below the average of 225.51K shares a day.
Over the past year Diebold Nixdorf has ranged from $54.48 to $92.09, and now sits 36% of the way up that range.
Diebold Nixdorf met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q2 FY26 it reported $1.10 per share against an estimate of $1.11.
The average analyst price target is $100.30, 47.8% above the current price, from 3 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy100.0%
- Hold0.0%
- Sell0.0%
- Low
- $95.95
- Now
- $67.84
- High
- $105.00
DBD earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 5 of the last 8 quarters, by 36.7% on average.
- Q3 FY24: reported $0.55 per share against an estimate of $1.15
- Q4 FY24: reported $0.97 per share against an estimate of $1.07
- Q1 FY25: reported $0.37 per share against an estimate of $0.3636
- Q2 FY25: reported $0.94 per share against an estimate of $0.5892
- Q3 FY25: reported $1.38 per share against an estimate of $0.9427
- Q4 FY25: reported $2.75 per share against an estimate of $1.64
- Q1 FY26: reported $0.67 per share against an estimate of $0.6212
- Q2 FY26: reported $1.10 per share against an estimate of $1.11
DBD news
- Press releasePRNewswire
- Press releasePRNewswire
Diebold Nixdorf to Conduct 2026 Third Quarter Investor Call on Oct. 28
- Press releasePRNewswire
DDI Wins Gold and Silver in 2026 Brandon Hall Group™ HCM Excellence Awards®
- Press releasePRNewswire
Thomaston Savings Bank Advances Self-Service Banking with Diebold Nixdorf DN Series® ATMs and Managed Services
- Press releasePRNewswire
Diebold Nixdorf Recognized as an Android™ Enterprise Gold Partner
- Press releasePRNewswire
Diebold Nixdorf Reports Second Quarter Financial Results; Company Grew Revenue, Adjusted EBITDA and Adjusted EPS
- Press releasePRNewswire
Diebold Nixdorf to Conduct 2026 Second Quarter Investor Call on July 29
- Press releasePRNewswire
Diebold Nixdorf to Participate in D.A. Davidson Technology and Consumer Conference
Similar companies
Companies in the same industry as Diebold Nixdorf
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
- MDEXMadison Technologies$0.0005−37.50%
- WFFWF Holding$0.0929−3.83%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.